| | | | |
CUSIP No. G2007L204 | | SCHEDULE 13D/A | | Page 8 of 10 Pages |
This Amendment No. 1 (“Amendment No. 1”) is being filed by Anson Funds Management LP (the “Investment Entity”), Anson Management GP LLC, Mr. Bruce R. Winson, Anson Advisors Inc., Mr. Amin Nathoo and Mr. Moez Kassam (collectively, the “Reporting Persons”) with respect to the ordinary shares, par value NIS 5.00 (the “Ordinary Shares” or the “Shares”) of Nano Dimension Ltd., a corporation incorporated under the laws of Israel (the “Issuer”). This Amendment No. 1 amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on March 10, 2023 (the “Original Schedule 13D”, and together with this Amendment No. 1, the “Schedule 13D”). Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported in the Schedule 13D. Information in response to each item shall be deemed to be incorporated by reference in all other items. Capitalized terms used but not defined in this Amendment No. 1 shall have the meanings ascribed to such terms in the Schedule 13D.
Item 3. | Source and Amount of Funds or Other Considerations |
Item 3 of the Schedule 13D is amended and restated as follows:
The ADSs representing the Ordinary Shares reported herein as being beneficially owned by the Reporting Persons were purchased using working capital of the Funds. An aggregate of approximately $40,201,926.41 (excluding brokerage commissions) was used to purchase ADSs representing Ordinary Shares reported as beneficially owned by the Reporting Persons in this Schedule 13D. Such securities were acquired through open market purchases.
Item 4. | Purpose of Transaction |
Item 4 of the Schedule 13D is amended and supplemented to include the following:
On March 27, 2023, the Issuer filed a lawsuit in federal court in New York against certain of the Reporting Persons (the “Reporting Person Defendants”) and certain third parties (the “Other Defendants”). A copy of the complaint filed by the Issuer (the “Complaint”) is filed herewith as Exhibit 99.3 and incorporated herein by reference, and any descriptions herein of the Complaint are qualified in their entirety by reference to the Complaint. The Reporting Persons believe that the allegations contained in the Complaint are without merit and intend to defend themselves vigorously.
Item 5. | Interest in Securities of the Issuer |
Items 5(a)-(c) of the Schedule 13D are amended and restated as follows:
(a) See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each of the Reporting Persons. The percentages used in this Schedule 13D are calculated based upon an aggregate of 253,205,493 Ordinary Shares outstanding as of March 28, 2023, as reported in the Issuer’s Annual Report of Foreign Private Issuer on Form 20-F filed with the Securities and Exchange Commission on March 30, 2023.
(b) See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.